The folks and dealings associated with Aardvark's history just seem a little sus to me, although maybe there's really nothing there to be concerned about. I can understand there's a lot of back scratching that goes on in business in general, but... it just peaked my interest when i noticed the association with Sorrento's Henry Ji who's a bit of a controversial character in biotech especially during Covid-era and served on Aardvark's board of directors following the transaction Sorrento struck with Aardvark (https://investors.sorrentotherapeutics.com/news-releases/news-release-details/sorrento-therapeutics-and-scilex-holding-majority-owned) Also Vickers being one of Aardvark's Series A investors, Vickers involvement with $SCLX which was majority owned by Sorrento and brought public via Vickers Vantage spac. I can only assume Ji and Aardvark's founder/CEO Tien Lee met while Lee was at NantKwest (most of Aardvark's leadership team came from $NK now $IBRX). Remember that Scilex was majority owned by Sorrento prior to their coming public in 2022, and Tien Lee Aardvark's CEO joined Scilex bod in late Feb '19. This was 2 years ahead of ARD-301 licensing by Sorrento/Scilex... and then there's the whole Sorrento bk. There's just so much incestuous stuff going on here, and yet, maybe it says nothing about the legitimacy of Aardvark. IDK.
News 
Market Data 
Discover 
